Results 31 to 40 of about 22,504 (208)
PLoS ONE, 2022 Hormonal fluctuations, such as the perinatal period, may increase susceptibility of women to depression, which in turn exert a negative impact on child's neurodevelopment, becoming a risk factor in development of neuropsychiatric disorders. Moreover, the
Mireia Viñas-Noguera +6 more
doaj +1 more source
Бюллетень сибирской медицины, 2021 Background. Mirtazapine is used to treat patients with depressive disorders. A large proportion of patients in this group do not adequately respond to mirtazapine therapy, while many develop undesirable drug reactions of type A. According to the previous
M. S. Zastrozhin +6 more
doaj +1 more source
Influence of body mass index on the choice of therapy for depression and follow-up care [PDF]
, 2014 Overweight and obese patients commonly suffer from depression and choice of depression therapy may alter weight. We conducted a cohort study to investigate whether obesity is associated with treatment choices for depression; and whether obesity is ...
Arterburn, David +6 more
core +1 more source
Mirtazapine versus fluoxetine in the treatment of panic disorder
Brazilian Journal of Medical and Biological Research, 2001 Mirtazapine is an antidepressant whose side effect profile differs from that of first-line agents (selective serotonin reuptake inhibitors) used in the treatment of panic disorder.
L. Ribeiro +6 more
doaj +1 more source
Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. [PDF]
, 2019 BackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is commonly administered to Major Depressive Disorder (MDD) patients taking psychotropic medications, yet the effects on treatment outcomes remain unknown.
Chawla, Shweta A +7 more
core +1 more source
The Effect of Mirtazapine on Cisplatin-Induced Oxidative Damage and Infertility in Rat Ovaries
The Scientific World Journal, 2013 Cisplatin causes infertility due to ovarian toxicity. The toxicity mechanism is unknown, but evidence suggests oxidative stress. In this study, the effect of mirtazapine on cisplatin-induced infertility and oxidative stress in rats was investigated.
Durdu Altuner +3 more
doaj +1 more source
BMC Medicine, 2022 Background Studies have reported an increased risk of mortality among people prescribed mirtazapine compared to other antidepressants. The study aimed to compare all-cause and cause-specific mortality between adults prescribed mirtazapine or other second-
Rebecca M. Joseph +7 more
doaj +1 more source
Post-mortem toxicology: A pilot study to evaluate the use of a Bayesian network to assess the likelihood of fatality [PDF]
, 2015 The challenge of interpreting post-mortem drug concentrations is well documented and relies on appropriate sample collection, knowledge of case circumstances as well as reference to published tables of data, whilst taking into account the known issues of
Bolton, Jennifer +3 more
core +1 more source
Pisa syndrome associated with mirtazapine: a case report
BMC Pharmacology and Toxicology, 2018 Background Mirtazapine is a noradrenergic and specific serotonergic antidepressant; its pharmacological profile indicates a low risk for dopaminergic adverse effects.
Yuji Yamada +6 more
doaj +1 more source
Sertraline and mirtazapine versus placebo in subgroups of depression in dementia: findings from the HTA-SADD randomized controlled trial [PDF]
, 2019 Objective Studies have shown that antidepressants are no better than placebo in treating depression in dementia. The authors examined antidepressant efficacy in subgroups of depression in dementia with different depressive symptom profiles.
Alexopoulos +36 more
core +6 more sources